|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
US5614184A
(en)
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
|
US5989538A
(en)
*
|
1995-02-15 |
1999-11-23 |
Amgen Inc. |
Mpl ligand analogs
|
|
US5696250A
(en)
*
|
1995-02-15 |
1997-12-09 |
Amgen Inc. |
DNA encoding megakaryocyte growth and development factor analogs
|
|
AU6964196A
(en)
*
|
1995-10-09 |
1997-04-30 |
Pharmacia & Upjohn Company |
An acceptor polypeptide for an n-acetylgalactosaminyltransferase
|
|
KR100400637B1
(ko)
*
|
1996-02-06 |
2004-03-10 |
씨제이 주식회사 |
생물학적으로유용한펩타이드
|
|
DK0888385T3
(da)
|
1996-03-14 |
2003-12-15 |
Genentech Inc |
GDNF receptor og anvendelser deraf
|
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
|
EP0902085B1
(en)
*
|
1997-09-01 |
2003-12-03 |
Aventis Pharma Deutschland GmbH |
Recombinant human erythropoietin with advantageous glycosylation profile
|
|
EP1489100B1
(en)
|
1997-12-08 |
2016-06-15 |
Merck Patent GmbH |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
|
|
CA2330527A1
(en)
|
1998-06-15 |
1999-12-23 |
Genzyme Transgenics Corporation |
Erythropoietin analog-human serum albumin fusion
|
|
AR020848A1
(es)
*
|
1998-10-23 |
2002-05-29 |
Amgen Inc |
Metodos y composiciones para la prevencion y el tratamiento de anemia
|
|
US7304150B1
(en)
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
DE19857609A1
(de)
|
1998-12-14 |
2000-06-15 |
Hannelore Ehrenreich |
Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
|
|
JP4841037B2
(ja)
*
|
1999-02-12 |
2011-12-21 |
アムジエン・インコーポレーテツド |
グリコシル化レプチン組成物および関連する方法
|
|
US7345019B1
(en)
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
|
US7410941B1
(en)
|
1999-04-13 |
2008-08-12 |
The Kenneth S. Warren Institute, Inc. |
Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
|
|
US8236561B2
(en)
|
1999-04-15 |
2012-08-07 |
Crucell Holland B.V. |
Efficient production of IgA in recombinant mammalian cells
|
|
US6855544B1
(en)
|
1999-04-15 |
2005-02-15 |
Crucell Holland B.V. |
Recombinant protein production in a human cell
|
|
US7604960B2
(en)
|
1999-04-15 |
2009-10-20 |
Crucell Holland B.V. |
Transient protein expression methods
|
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
US6831060B2
(en)
|
1999-05-07 |
2004-12-14 |
Genentech, Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
|
US6555343B1
(en)
|
1999-05-07 |
2003-04-29 |
Genentech Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
|
IL145785A0
(en)
*
|
1999-05-07 |
2002-07-25 |
Genentech Inc |
Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
|
|
CZ299516B6
(cs)
*
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
PE20010288A1
(es)
*
|
1999-07-02 |
2001-03-07 |
Hoffmann La Roche |
Derivados de eritropoyetina
|
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
JP2003514552A
(ja)
*
|
1999-11-12 |
2003-04-22 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
改善された性質を有するエリトロポエチンの形態
|
|
US7527961B2
(en)
|
1999-11-26 |
2009-05-05 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7192759B1
(en)
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7091321B2
(en)
|
2000-02-11 |
2006-08-15 |
Emd Lexigen Research Center Corp. |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
US6586398B1
(en)
*
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
WO2001081405A2
(en)
*
|
2000-04-21 |
2001-11-01 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
JP3967594B2
(ja)
*
|
2000-05-15 |
2007-08-29 |
エフ．ホフマン−ラ ロシュ アーゲー |
新しい薬剤組成物
|
|
US7259146B2
(en)
|
2000-05-26 |
2007-08-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Neuroprotective peptides
|
|
AU2001276737A1
(en)
|
2000-08-04 |
2002-02-18 |
Chugai Seiyaku Kabushiki Kaisha |
Protein injection preparations
|
|
JP5485489B2
(ja)
|
2000-08-11 |
2014-05-07 |
中外製薬株式会社 |
抗体含有安定化製剤
|
|
KR101229995B1
(ko)
|
2000-12-11 |
2013-02-06 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
AU2002222740A1
(en)
*
|
2000-12-11 |
2002-06-24 |
Cheil Jedang Corporation |
Fusion protein having the enhanced in vivo activity of erythropoietin
|
|
CA2431964C
(en)
*
|
2000-12-20 |
2013-09-10 |
F. Hoffmann-La Roche Ag |
Conjugates of erythropoietin (pep) with polyethylene glycol (peg)
|
|
US6531121B2
(en)
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
US20030072737A1
(en)
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
|
US7767643B2
(en)
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
|
EP1471871B1
(en)
|
2001-02-02 |
2007-05-02 |
Ortho-McNeil Pharmaceutical, Inc. |
Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
|
|
JP4234438B2
(ja)
|
2001-03-07 |
2009-03-04 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
ハイブリッド・イソタイプ抗体部分を含有する蛋白質の発現技術
|
|
EP2336149A1
(en)
|
2001-03-09 |
2011-06-22 |
Chugai Seiyaku Kabushiki Kaisha |
Protein purification method
|
|
DE10112825A1
(de)
|
2001-03-16 |
2002-10-02 |
Fresenius Kabi De Gmbh |
HESylierung von Wirkstoffen in wässriger Lösung
|
|
WO2002079415A2
(en)
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
|
FR2823220B1
(fr)
*
|
2001-04-04 |
2003-12-12 |
Genodyssee |
Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
|
|
EP1382964A4
(en)
|
2001-04-17 |
2009-06-10 |
Chugai Pharmaceutical Co Ltd |
METHOD FOR TENSID QUANTIFICATION
|
|
DE60239454D1
(de)
|
2001-05-03 |
2011-04-28 |
Merck Patent Gmbh |
Rekombinanter, tumorspezifischer antikörper und dessen verwendung
|
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
|
US7214660B2
(en)
*
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
|
CA2468499A1
(en)
|
2001-11-28 |
2003-06-05 |
Ortho-Mcneil Pharmaceutical, Inc. |
Erythropoietin dosing regimen for treating anemia
|
|
KR100467750B1
(ko)
*
|
2001-11-29 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
KR100467751B1
(ko)
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
WO2003048334A2
(en)
|
2001-12-04 |
2003-06-12 |
Merck Patent Gmbh |
Immunocytokines with modulated selectivity
|
|
DE60224843T2
(de)
|
2001-12-07 |
2009-01-08 |
Crucell Holland B.V. |
Herstellung von viren, virusisolaten, und impfstoffen
|
|
PT1463751E
(pt)
|
2001-12-21 |
2013-08-26 |
Human Genome Sciences Inc |
Proteínas de fusão de albumina
|
|
DE10209822A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
|
|
DE10209821A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
|
AU2003218045A1
(en)
|
2002-03-11 |
2003-09-29 |
Ortho Mcneil Pharmaceutical, Inc |
Methods for shp1 mediated neuroprotection
|
|
US20030191056A1
(en)
|
2002-04-04 |
2003-10-09 |
Kenneth Walker |
Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
|
|
CA2491567A1
(en)
*
|
2002-07-01 |
2004-01-08 |
The Kenneth S. Warren Institute, Inc. |
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
|
|
AU2003246486A1
(en)
*
|
2002-07-19 |
2004-02-09 |
Cangene Corporation |
Pegylated erythropoietic compounds
|
|
DE10234192B4
(de)
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
US20060058511A1
(en)
|
2002-08-27 |
2006-03-16 |
Chugai Seiyaku Kabushiki Kaisha |
Method for stabilizing protein solution preparation
|
|
US7459435B2
(en)
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
|
ATE466085T1
(de)
|
2002-09-09 |
2010-05-15 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
|
DE20321793U1
(de)
|
2002-09-11 |
2010-06-02 |
Fresenius Kabi Deutschland Gmbh |
Hydroxyalkylstärke-Derivate
|
|
EP3225625A1
(en)
|
2002-09-11 |
2017-10-04 |
Chugai Seiyaku Kabushiki Kaisha |
Protein purification method
|
|
CN100348618C
(zh)
|
2002-09-11 |
2007-11-14 |
弗雷泽纽斯卡比德国有限公司 |
生产羟烷基淀粉衍生物的方法
|
|
EP1681303B1
(en)
|
2002-09-11 |
2013-09-04 |
Fresenius Kabi Deutschland GmbH |
HASylated polypeptides, especially HASylated erythropoietin
|
|
WO2004032971A1
(en)
|
2002-10-08 |
2004-04-22 |
Fresenius Kabi Deutschland Gmbh |
Pharmaceutically active oligosaccharide conjugates
|
|
CA2502539A1
(en)
*
|
2002-10-17 |
2004-04-29 |
Pharming Intellectual Property B.V. |
Protein modification
|
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
|
US7169904B2
(en)
|
2002-12-17 |
2007-01-30 |
Emd Lexigen Research Center Corp. |
Immunocytokine sequences and uses thereof
|
|
EP1615945B1
(en)
|
2003-04-09 |
2011-09-28 |
BioGeneriX AG |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
CN100383238C
(zh)
|
2003-05-09 |
2008-04-23 |
克鲁塞尔荷兰公司 |
E1-永生化的细胞培养物及培养所述细胞以提高从中获取的产物产量的方法
|
|
US9005625B2
(en)
|
2003-07-25 |
2015-04-14 |
Novo Nordisk A/S |
Antibody toxin conjugates
|
|
WO2005014655A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
|
ZA200603396B
(en)
|
2003-09-29 |
2007-11-28 |
Warren Pharmaceuticals Inc |
Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
|
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
ES2346226T3
(es)
|
2003-12-30 |
2010-10-13 |
Augustinus Bader |
Uso de la eritropoyetina para la regeneracion de tejido hepatico.
|
|
DE102004063927A1
(de)
|
2004-01-23 |
2005-12-15 |
Epoplus Gmbh Co.Kg |
Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
|
|
CA2558738C
(en)
|
2004-03-11 |
2013-02-05 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
|
|
US20080300173A1
(en)
|
2004-07-13 |
2008-12-04 |
Defrees Shawn |
Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
CA2585758C
(en)
|
2004-10-29 |
2017-08-01 |
Neose Technologies, Inc. |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
|
NZ556436A
(en)
|
2005-01-10 |
2010-11-26 |
Biogenerix Ag |
Glycopegylated granulocyte colony stimulating factor
|
|
EP2386571B1
(en)
|
2005-04-08 |
2016-06-01 |
ratiopharm GmbH |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
|
US9988427B2
(en)
|
2005-05-13 |
2018-06-05 |
Charite Universitaetsmedizen-Berlin |
Erythropoietin variants
|
|
EP1736481A1
(en)
|
2005-05-13 |
2006-12-27 |
Charite Universitätsmedizin-Berlin |
Erythropoietin variants
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
CN100432107C
(zh)
*
|
2005-10-25 |
2008-11-12 |
北京大学 |
具有促红细胞生长因子活性的蛋白质及其用途
|
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
|
US7888101B2
(en)
|
2005-12-08 |
2011-02-15 |
Amgen Inc. |
Host cells comprising alpha 1,2 mannosidase and culture methods thereof
|
|
AU2006324163B2
(en)
|
2005-12-08 |
2013-05-02 |
Amgen Inc. |
Improved production of glycoproteins using manganese
|
|
DE102006004008A1
(de)
|
2006-01-27 |
2007-08-02 |
Hannelore Prof. Dr. Dr. Ehrenreich |
Verfahren zur Behandlung und/oder Prophylaxe von Multipler Sklerose, sowie Verwendung von Erythropoietin zur Herstellung eines Arzneimittels zur intermittierenden Behandlung und/oder intermittierenden Prophylaxe von Multipler Sklerose
|
|
EP1997505A4
(en)
|
2006-03-22 |
2013-02-13 |
Chugai Pharmaceutical Co Ltd |
PREPARATION OF ERYTHROPOIETIN SOLUTION
|
|
CN101062407A
(zh)
|
2006-04-29 |
2007-10-31 |
中国科学院上海生命科学研究院 |
促红细胞生成素在预防或治疗视网膜损伤中的用途
|
|
CA2652578A1
(en)
|
2006-05-19 |
2007-11-29 |
Glycofi, Inc. |
Erythropoietin compositions
|
|
US20090173876A1
(en)
|
2006-07-21 |
2009-07-09 |
Amgen Inc. |
Method of detecting and/or measuring hepcidin in a sample
|
|
CN101516388B
(zh)
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
|
CA2661054A1
(en)
|
2006-08-22 |
2008-02-28 |
Chugai Seiyaku Kabushiki Kaisha |
Prophylactic and/or therapeutic agents for peripheral neuropathy
|
|
EP2054521A4
(en)
|
2006-10-03 |
2012-12-19 |
Novo Nordisk As |
PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES
|
|
CN101337988B
(zh)
*
|
2006-10-31 |
2013-01-09 |
沈阳三生制药有限责任公司 |
一种新的促红细胞生成素类似物
|
|
EP2081956B1
(en)
|
2006-11-13 |
2013-03-20 |
Charité - Universitätsmedizin Berlin |
Method of cell culture and method of treatment comprising a vepo protein variant
|
|
EP2120998B1
(en)
|
2006-11-28 |
2013-08-07 |
HanAll Biopharma Co., Ltd. |
Modified erythropoietin polypeptides and uses thereof for treatment
|
|
AR065613A1
(es)
|
2007-03-09 |
2009-06-17 |
Chugai Pharmaceutical Co Ltd |
Agentes de proteccion para organos transplantados
|
|
JP2010523582A
(ja)
|
2007-04-03 |
2010-07-15 |
バイオジェネリクス アクチェンゲゼルシャフト |
グリコｐｅｇ化ｇ−ｃｓｆを用いた治療方法
|
|
EP2170919B8
(en)
|
2007-06-12 |
2016-01-20 |
ratiopharm GmbH |
Improved process for the production of nucleotide sugars
|
|
EP2167115A2
(en)
*
|
2007-06-15 |
2010-03-31 |
University Of Zurich |
Treatment for alzheimer's disease
|
|
CN103073631A
(zh)
*
|
2007-07-02 |
2013-05-01 |
沈阳三生制药有限责任公司 |
一种促红细胞生成素类似物
|
|
CN103113464B
(zh)
*
|
2007-07-02 |
2014-08-20 |
沈阳三生制药有限责任公司 |
天然人促红细胞生成素类似物
|
|
WO2009010107A1
(en)
|
2007-07-19 |
2009-01-22 |
Hannelore Ehrenreich |
Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis
|
|
US8383114B2
(en)
|
2007-09-27 |
2013-02-26 |
Amgen Inc. |
Pharmaceutical formulations
|
|
EP3381445B1
(en)
|
2007-11-15 |
2023-10-25 |
Amgen Inc. |
Aqueous formulation of antibody stablised by antioxidants for parenteral administration
|
|
EP2070950A1
(en)
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Hydroxyalkyl starch derivatives and process for their preparation
|
|
CA2711826C
(en)
|
2008-01-25 |
2018-02-27 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
|
US9938333B2
(en)
|
2008-02-08 |
2018-04-10 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
|
CN103497247A
(zh)
|
2008-02-27 |
2014-01-08 |
诺沃—诺迪斯克有限公司 |
缀合的因子viii分子
|
|
EP2095829A1
(en)
|
2008-02-27 |
2009-09-02 |
LEK Pharmaceuticals D.D. |
Selenium containing modifying agents and conjugates
|
|
JP5665733B2
(ja)
|
2008-04-21 |
2015-02-04 |
ノボ ノルディスク ヘルス ケア アーゲー |
高度にグリコシル化されたヒト凝固第ｉｘ因子
|
|
AU2009246946B2
(en)
|
2008-05-01 |
2013-09-26 |
Amgen Inc. |
Anti-hepcidin antibodies and methods of use
|
|
ES2435272T3
(es)
|
2008-09-23 |
2013-12-17 |
F. Hoffmann-La Roche Ag |
Purificación de la eritropoyetina
|
|
HUE035168T2
(en)
|
2008-09-26 |
2018-05-02 |
Ambrx Inc |
Modified animal erythropoietin polypeptides and their applications
|
|
EP3693014A1
(en)
|
2008-11-13 |
2020-08-12 |
The General Hospital Corporation |
Methods and compositions for regulating iron homeostasis by modulation bmp-6
|
|
PT2398817E
(pt)
*
|
2009-02-19 |
2015-08-28 |
Xellia Pharmaceuticals Aps |
Processo para purificar lipopéptidos
|
|
US20100272816A1
(en)
|
2009-04-27 |
2010-10-28 |
Wolfgang Rudinger |
Microcapsules comprising liver cells and erythropoietin, methods for preparing said microcapsules and methods for treating a patient comprising applying said microcapsules to the patient
|
|
WO2011011674A2
(en)
|
2009-07-24 |
2011-01-27 |
Dr. Reddy's Laboratories Ltd. |
Production of erythropoiesis stimulating protein using metal ions
|
|
WO2011024025A1
(en)
*
|
2009-08-28 |
2011-03-03 |
Avesthagen Limited |
An erythropoietin analogue and a method thereof
|
|
MX344382B
(es)
|
2009-10-23 |
2016-12-14 |
Amgen Inc * |
Adaptador de vial y sistema.
|
|
ES2545411T5
(es)
|
2010-06-07 |
2024-04-05 |
Amgen Inc |
Dispositivo de administración de fármaco
|
|
US8193296B2
(en)
|
2010-06-30 |
2012-06-05 |
Nike, Inc. |
Golf balls including crosslinked thermoplastic polyurethane
|
|
US20120115637A1
(en)
|
2010-06-30 |
2012-05-10 |
Nike, Inc. |
Golf Balls Including A Crosslinked Thermoplastic Polyurethane Cover Layer Having Improved Scuff Resistance
|
|
RU2451071C1
(ru)
*
|
2010-12-10 |
2012-05-20 |
Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) |
Штамм гибридных культивируемых клеток животных mus musculus - продуцент моноклональных антител к рекомбинантному эритропоэтину человека (варианты)
|
|
EP2691065B1
(en)
|
2011-03-31 |
2017-03-01 |
Amgen Inc. |
Vial adapter and system
|
|
SI2699293T1
(sl)
|
2011-04-20 |
2019-05-31 |
Amgen Inc. |
Avtoinjekcijski aparat
|
|
US9089739B2
(en)
|
2011-08-23 |
2015-07-28 |
Nike, Inc. |
Multi-core golf ball having increased initial velocity
|
|
US8979676B2
(en)
|
2011-08-23 |
2015-03-17 |
Nike, Inc. |
Multi-core golf ball having increased initial velocity at high swing speeds relative to low swing speeds
|
|
CN103930142B
(zh)
|
2011-10-14 |
2016-12-14 |
安姆根有限公司 |
注射器和装配方法
|
|
KR101443257B1
(ko)
*
|
2011-10-18 |
2014-09-19 |
주식회사 종근당 |
낮은 등전점을 갖는 에리스로포이에틴 유사체의 정제방법
|
|
CN102788720B
(zh)
*
|
2012-06-05 |
2016-01-06 |
西北大学 |
一种滤膜辅助分离生物样本中糖蛋白全n-连接糖链及其鉴别方法
|
|
JP2015535464A
(ja)
|
2012-11-21 |
2015-12-14 |
アムジエン・インコーポレーテツド |
薬剤送達装置
|
|
CN103864913A
(zh)
*
|
2012-12-18 |
2014-06-18 |
联亚生技开发股份有限公司 |
重组蛋白
|
|
EP2968760B1
(en)
|
2013-03-15 |
2024-01-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
SG11201507417RA
(en)
|
2013-03-15 |
2015-10-29 |
Amgen Inc |
Body contour adaptable autoinjector device
|
|
CA2904357C
(en)
|
2013-03-15 |
2020-09-22 |
Intrinsic Lifesciences Llc |
Anti-hepcidin antibodies and uses thereof
|
|
CA2904661C
(en)
|
2013-03-15 |
2022-03-15 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
WO2014149357A1
(en)
|
2013-03-22 |
2014-09-25 |
Amgen Inc. |
Injector and method of assembly
|
|
EP3957345A1
(en)
|
2013-10-24 |
2022-02-23 |
Amgen, Inc |
Drug delivery system with temperature-sensitive control
|
|
WO2015061386A1
(en)
|
2013-10-24 |
2015-04-30 |
Amgen Inc. |
Injector and method of assembly
|
|
KR101414897B1
(ko)
|
2013-11-29 |
2014-07-04 |
씨제이헬스케어 주식회사 |
다베포에틴 알파의 정제 방법
|
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
KR102496507B1
(ko)
|
2014-05-07 |
2023-02-03 |
암겐 인코포레이티드 |
충격 감소 요소들을 가진 자동 주사기
|
|
MX2016015851A
(es)
|
2014-06-03 |
2017-07-19 |
Amgen Inc |
Sistemas y metodos para procesar de manera remota datos recolectados por un dispositivo de suministro de farmaco.
|
|
EP3194429A4
(en)
*
|
2014-09-18 |
2018-06-13 |
Askgene Pharma, Inc. |
Novel feline erythropoietin receptor agonists
|
|
NZ730186A
(en)
|
2014-09-22 |
2020-04-24 |
Intrinsic Lifesciences Llc |
Humanized anti-hepcidin antibodies and uses thereof
|
|
AU2015332557B2
(en)
|
2014-10-14 |
2020-05-14 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
WO2016100781A1
(en)
|
2014-12-19 |
2016-06-23 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
JP2017538512A
(ja)
|
2014-12-19 |
2017-12-28 |
アムジエン・インコーポレーテツド |
ライブボタンまたはユーザインタフェースフィールドを含む薬物送達装置
|
|
US10583245B2
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
EP3261690B1
(en)
|
2015-02-27 |
2021-12-15 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
US10604779B2
(en)
|
2016-03-09 |
2020-03-31 |
Jcr Pharmaceuticals Co., Ltd. |
Method for production of mutant-type human erythropoietin
|
|
EP3429663B1
(en)
|
2016-03-15 |
2020-07-15 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
EP3455142B1
(en)
|
2016-05-13 |
2023-08-09 |
Amgen Inc. |
Vial sleeve assembly
|
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
GB2550418A
(en)
|
2016-05-20 |
2017-11-22 |
Laing Peter |
An improved vaccine against flaviviruses avoiding elicitation or stimulation of infection-enhancing antibodies
|
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
US11285266B2
(en)
|
2016-07-01 |
2022-03-29 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
|
CA3049780A1
(en)
|
2017-01-17 |
2018-07-26 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
CA3048520A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
JP6258536B1
(ja)
*
|
2017-03-03 |
2018-01-10 |
協和発酵キリン株式会社 |
ダルベポエチン組成物の製造方法およびダルべポエチン産生細胞の培養方法
|
|
JP2020508803A
(ja)
|
2017-03-06 |
2020-03-26 |
アムジエン・インコーポレーテツド |
作動防止特徴部を備える薬物送達デバイス
|
|
KR102627069B1
(ko)
|
2017-03-07 |
2024-01-18 |
암겐 인코포레이티드 |
과압에 의한 바늘 삽입
|
|
MX2019010671A
(es)
|
2017-03-09 |
2019-10-21 |
Amgen Inc |
Mecanismo de insercion para dispositivo de administracion de farmacos.
|
|
WO2018172219A1
(en)
|
2017-03-20 |
2018-09-27 |
F. Hoffmann-La Roche Ag |
Method for in vitro glycoengineering of an erythropoiesis stimulating protein
|
|
FI3600491T3
(fi)
|
2017-03-28 |
2023-10-20 |
Amgen Inc |
Männänvarren ja ruiskukokoonpanon järjestelmä ja menetelmä
|
|
CN110997707A
(zh)
|
2017-06-06 |
2020-04-10 |
金德雷德生物科学股份有限公司 |
兽用促红细胞生成素和类似物
|
|
EP3634546A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Torque driven drug delivery device
|
|
US11590294B2
(en)
|
2017-06-08 |
2023-02-28 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
US11541183B2
(en)
|
2017-06-22 |
2023-01-03 |
Amgen Inc. |
Device activation impact/shock reduction
|
|
MX2019015479A
(es)
|
2017-06-23 |
2020-02-20 |
Amgen Inc |
Dispositivo electronico de administracion de farmacos con tapa accionada por un conjunto de conmutador.
|
|
ES2972207T3
(es)
|
2017-07-14 |
2024-06-11 |
Amgen Inc |
Sistema de inserción-retracción de agujas con sistema de resorte de torsión doble
|
|
US11672733B2
(en)
|
2017-07-21 |
2023-06-13 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
WO2019022950A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF
|
|
MA49677A
(fr)
|
2017-07-25 |
2021-04-21 |
Amgen Inc |
Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé
|
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
|
MA49897A
(fr)
|
2017-08-18 |
2020-06-24 |
Amgen Inc |
Injecteur sur-corps avec patch adhésif stérile
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
EP3691716B1
(en)
|
2017-10-06 |
2023-11-29 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
|
US11464903B2
(en)
|
2017-10-09 |
2022-10-11 |
Amgen Inc. |
Drug delivery device with drive assembly and related method of assembly
|
|
IL273663B1
(en)
|
2017-11-03 |
2025-01-01 |
Amgen Inc |
System and methods for disinfecting a drug delivery device
|
|
ES2994389T3
(en)
|
2017-11-06 |
2025-01-23 |
Amgen Inc |
Drug delivery device with placement and flow sensing
|
|
MA50569A
(fr)
|
2017-11-06 |
2020-09-16 |
Amgen Inc |
Ensembles de remplissage-finition et procédés associés
|
|
CA3079665A1
(en)
|
2017-11-10 |
2019-05-16 |
Amgen Inc. |
Plungers for drug delivery devices
|
|
JP2021503311A
(ja)
|
2017-11-16 |
2021-02-12 |
アムジエン・インコーポレーテツド |
失速及び終点検出を有するオートインジェクタ
|
|
EP3710090A1
(en)
|
2017-11-16 |
2020-09-23 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
WO2020023444A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
WO2020028009A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
US20210346601A1
(en)
|
2018-09-24 |
2021-11-11 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
AR113091A1
(es)
*
|
2018-09-27 |
2020-01-22 |
Univ Nacional Del Litoral |
Eritropoyetina humana modificada
|
|
MA53718A
(fr)
|
2018-09-28 |
2022-01-05 |
Amgen Inc |
Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament
|
|
CN112805048B
(zh)
|
2018-10-02 |
2023-09-22 |
安进公司 |
具有内部力传递的用于药物递送的注射系统
|
|
WO2020072846A1
(en)
|
2018-10-05 |
2020-04-09 |
Amgen Inc. |
Drug delivery device having dose indicator
|
|
US12053617B2
(en)
|
2018-10-15 |
2024-08-06 |
Amgen Inc. |
Drug delivery device having damping mechanism
|
|
US20210346596A1
(en)
|
2018-10-15 |
2021-11-11 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
EP3873566B1
(en)
|
2018-11-01 |
2024-11-27 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
IL281908B1
(en)
|
2018-11-01 |
2025-02-01 |
Amgen Inc |
Drug delivery devices with partial drug delivery unit withdrawal
|
|
AU2020263289A1
(en)
|
2019-04-24 |
2021-09-16 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
CA3148261A1
(en)
|
2019-08-23 |
2021-03-04 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
WO2022159414A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Rochester |
Erythropoietin for gastroinfestinal dysfunction
|
|
WO2022246055A1
(en)
|
2021-05-21 |
2022-11-24 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
|
WO2023209074A1
(en)
|
2022-04-28 |
2023-11-02 |
Institut National de la Santé et de la Recherche Médicale |
Methods of restoring erythropoiesis in patients suffering from a sf3b1 mutant myelodysplastic syndrome by correcting coasy mis-splicing
|
|
WO2024094457A1
(en)
|
2022-11-02 |
2024-05-10 |
F. Hoffmann-La Roche Ag |
Method for producing glycoprotein compositions
|